Companies

Agappe Diagnostics, Hitachi Chemical join hands to make clinical chemistry analysers

V.Sajeev Kumar Kochi | Updated on January 12, 2018 Published on May 25, 2017

Agappe Diagnostics, a leading diagnostic reagents and equipment manufacturers, has joined hands with Hitachi Chemical Company to manufacture advanced fully-automatic specific protein and clinical chemistry analysers in India through a technology licensing pact.

Thomas John, Managing Director, Agappe Diagnostics, said manufacture of the equipment, through a Hitachi Chemical technology licensing agreement, would commence at the company's facility in Pattimattom near Kochi and the product would be launched by next year.

The initiative, once it becomes functional, would also mark the beginning of clinical laboratories all over embracing the automation mode, thereby, enhancing the quality of tests and accuracy of results, he said.

The new project would also create better employment opportunities as well as serve as a breakthrough in R&D. Affordable pricing would help rural penetration with medium and smaller labs also entering the platform for advanced testing. The instrument provides ease of operation, fast and highly specific results at a reduced cost estimated at roughly one-third of the cost per test, compared to the conventional method analysers, he added.

The new instrument also enables early detection of kidney malfunction, cardiac problems and osteoporosis. It can also support detection of prostate cancer through PSA testing and TB detection trough ADA testing.

“We are confident that this association will bring both Agappe and Hitachi Chemical to new heights and also enable us to deliver the best in class diagnostic solutions to the common man at an affordable price,” said Tsuyoshi Uchida, Deputy General Manager, Medical Business Unit, Hitachi Chemical.



Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 25, 2017
This article is closed for comments.
Please Email the Editor